Clinical Sciences at Monash Health

In February 2021 we focused on MARC members from the school of Clinical Sciences at Monash Health.

The School of Clinical Sciences at Monash Health (SCS) is a health professional school and research centre of excellence based at campuses of Monash Health, Victoria’s largest hospital network. Read more


Professor Suresh Sundram is the Head, Department of Psychiatry, School of Clinical Sciences, Monash University and Director of Research, Mental Health Program, Monash Health.

He has been investigating the molecular pathology of schizophrenia and related psychotic disorders using pharmacological, neurochemical and neuropathological approaches. These inter-related methods have been applied to parse components of the disorder, such as treatment resistance and suicide to better understand their neurobiological substrates. He undertook his doctoral and post-doctoral studies at the Mental Health Research Institute in Melbourne before establishing his laboratory there and subsequently at the Florey Institute and concurrently establishing a clinical research laboratory undertaking clinical trial and biomarker research in psychotic disorders. He then transferred to, and integrated his research program at Monash University and Monash Medical Centre. Together, this has permitted rapid and seamless translational research between molecular and clinical approaches. The work has resulted in more than 150 published scientific articles, books, book chapters and conference abstracts. He has presented as plenary and invited speaker at international and national conferences, served as deputy editor for the Asian Journal of Psychiatry and is an advisor to the UN, national and state governments.

Prof Sundram currently collaborates with MARC members on the following projects:

‘A Phase 2A randomised double-blind active-placebo-controlled trial to assess the safety and efficacy of psilocybin-assisted psychotherapy for Generalised Anxiety Disorder’

MARC Co-investigators: Prof Murat Yucel (Turner Institute)

‘An open-label safety and efficacy trial of MDMA-assisted psychotherapy for severe PTSD’

MARC Co-investigators: Prof Murat Yucel (Turner Institute)


Professor Diana Egerton-Warburton, OAM, is an Emergency Physician with a passion for patient and community advocacy. She is a Professor at the School of Clinical Sciences at Monash Health, Monash University and the Co-Chair of Monash University’s Emergency Research Collaborative (MERC).  She has led and participated in a number of multi-site clinical trials and clinical research projects, with an emphasis on focused on pragmatic, patient-centered research, to influence practice. She has received numerous research grants including NHMRC and VicHealth. She is chair of the Australasian College for Emergency Medicine Public Health Committee and has led an international project to highlight and reduce the harmful effects of alcohol. She is a member of the Australian National Advisory Council on Alcohol and other Drugs (ANACAD) providing policy advice to the Commonwealth Government. As a supporter of #foamED (Free Open Access Medical Education) she believes in the use of social media as an education, research and advocacy tool.


Dr Matthew Frei is an adjunct senior lecturer at Monash University and the Clinical Director, Turning Point Treatment Services. Dr Frei holds a Bachelor of Medicine/Bachelor of Surgery (MBBS). Having seen addiction medicine grow out of a small group of dedicated doctors to what is now a recognised speciality within the Royal Australasian College of Physicians, he has been fortunate to have the opportunity to contribute to the specialty. He is a Fellow of the Australasian Chapter of Addiction Medicine and served a term as Chapter President. While much of his role involves governance of a constantly growing clinical team, Dr Frei is a clinician and enjoys working with people seeking help. His role at Turning Point enables him to inform the development of high-quality systems and support the professionals who work within them.

Dr Frei’s professional clinical interests include pain and pharmaceutical drug dependence, and he works sessionally for Alfred Health in their Caulfield based Pain Management Centre. Dr Frei has also worked extensively in doctor's health and continues to work in assessment and management of health professionals affected by addiction. He has provided expert medical-legal opinions on many substance use cases, including for the Coroner's Court, private insurers and professional regulatory bodies.

Dr Frei has been involved in addiction medicine clinical research with author and co-author credits on a range of papers published in peer-reviewed journals. He is passionate about supporting the training of doctors in alcohol and other drug medicine. He enjoys teaching on both an individual and group level and is an adjunct senior lecturer at Monash University.